subscribe
 

Discovery of new mechanism for tumour suppression

Researchers describe how damaged cells can be inhibited from multiplying



Novel microfluidic platform for cancer research

Multidisciplinary approach creates a novel microfluidic platform for cancer research



Optical microscope quadruples its magnification

Possible for the first time to view the structure of viruses with a regular microscope



New approach in T-cell therapy to treat cancer

Surface molecule causes the cells to respond particularly aggressively when they encounter a protein that tumours actually use to camouflage themselves from the immune system



Automated workflow for cancer research

Brad Larson and Glauco Souza on automated, label-free image- based methods to monitor inhibition of metastatic cell migration in 3D colorectal cancer models



Faster confocal imaging

Microscope combines high-performance imaging capabilities with ease of use so researchers in fields such as cell biology, cancer research and stem cell research



Cold sore virus could treat cancer

Scientists publish research on using modified herpes virus to treat skin cancer



Discovery may lead to alternative methods to treat women with a high risk of breast and ovarian cancer

Queen’s University discovery could signal new, drug-based ways to treat women instead of turning to surgery



First human implantation of an artificial larynx

ProTip and Strasbourg University Hospitals announce the first human implantation of an artificial larynx



Collagen clue reveals new drug target for untreatable form of lung cancer

Collagen, the stuff of ligaments and skin, and the most abundant protein in the human body, has an extraordinary role in triggering chemical signals that help protect the body from cancer, a new study reveals.



Young female cancer patients unhappy with fertility discussions

Young female cancer patients are unhappy about the way fertility preservation options are discussed with them by doctors before starting cancer treatment, according to a new study by researchers from the University of Sheffield and The Children's Hospital, Sheffield.



Study reveals new dietary risk factors for colorectal cancer

Fizzy drinks, cakes, biscuits, crisps and deserts have all been identified as risk factors for bowel cancer, according to new research.



New 3D disease map will aid diagnosis

Scientists have made a significant discovery about genetic mutations linked to a wide range of diseases, including cancer, which could pave the way for better treatments.



Roche’s Avastin approved in Japan

First approval of Avastin for the treatment of newly diagnosed glioblastoma in combination with radiotherapy and temozolomide chemotherapy



Drug-resistant tumours

A Personal DeltaVision cell microscopy imaging system supplied by Image Solutions UK Ltd. is assisting scientists at Cancer Research UK to understand how tumours develop drug resistance.



Cutting edge breast cancer research

Gene expression test distinguishes between breast cancer patients at high and low risk of late recurrence



Genomics to reshape endometrial cancer treatment

The most in-depth look yet at endometrial cancer shows that adding genomics-based testing to the standard diagnostic workup could change the recommended course of treatment for some women.



Queen’s leads €6million European study to combat bowel cancer

Queen’s University has announced it is to lead a €6 million European study to find new treatments for bowel cancer.



IBM and Swiss Hospital test new tool for diagnosing cancer

IBM scientists are collaborating with pathologists at the University Hospital Zürich to test a new proto-type tool to accurately diagnose different types of cancer.



Chemotherapy before radiotherapy for testicular cancer could reduce risk of relapse and long-term side-effects

Giving men with testicular cancer a single dose of chemotherapy alongside radiotherapy could improve the effectiveness of treatment and reduce the risk of long-term side-effects, a new study reports.
 
As many as 96% of men with testicular cancer now survive at least ten years from diagnosis, but more advanced forms need to be treated with combination chemotherapy – which can have serious long-term complications.
 




Pages

Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe